Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1701459

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Semaglutide: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking with pharmaceutical companies to increase the supply of semaglutide.
tabling member constituency	West Lancashire
tabling member printed	Ashley Dalton
uin	22201
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.</p><p>We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 22202 22203 question first answered 22/04/2024 09:40:27 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4981 label Biography information for Ashley Dalton

1701460

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Semaglutide: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from type 2 diabetes.
tabling member constituency	West Lancashire
tabling member printed	Ashley Dalton
uin	22202
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.</p><p>We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 22201 22203 question first answered 22/04/2024 09:40:27 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4981 label Biography information for Ashley Dalton

1701461

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is working with her international counterparts to tackle supply issues relating to (a) semaglutide and (b) other glucagon-like peptide-1 receptor agonists licensed for treating patients with type 2 diabetes.
tabling member constituency	West Lancashire
tabling member printed	Ashley Dalton
uin	22203
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.</p><p>We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 22201 22202 question first answered 22/04/2024 09:40:27 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4981 label Biography information for Ashley Dalton

1672643

registered interest
date	23/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Weather
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help prepare the NHS for winter 2023-24.
tabling member constituency	West Lancashire
tabling member printed	Ashley Dalton
uin	3561
answer	answer is ministerial correction date of answer 28/11/2023 answer text <p>Winter planning for the National Health Service started earlier this year than in previous years. The urgent and emergency care recovery plan was published in January 2023 which included £1 billion of dedicated funding to support capacity. In July 2023, NHS England wrote to integrated care boards, trusts and primary care networks to set out a national approach to 2023/24 winter planning and the key steps to be taken across all parts of the system to meet the challenges expected from winter pressures.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 28/11/2023 09:44:56 answering member 4527 label Biography information for Helen Whately
tabling member	4981 label Biography information for Ashley Dalton

1672644

registered interest
date	23/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of elective surgeries cancelled in the last 12 months.
tabling member constituency	West Lancashire
tabling member printed	Ashley Dalton
uin	3562
answer	answer is ministerial correction date of answer 29/11/2023 answer text <p>Official NHS England statistics show that between September 2023 and September 2024 (latest National Health Service published data) the total number of elective surgeries cancelled in England for non-clinical reasons was 76,021. Some common non-clinical reasons for cancellations by the hospital include ward beds being unavailable, surgeon or theatre staff being unavailable, or emergency cases needing the theatre.</p><p>Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/cancelled-ops-data/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/cancelled-ops-data/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 29/11/2023 14:35:46 answering member 4044 label Biography information for Andrew Stephenson previous answer version 3976 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4981 label Biography information for Ashley Dalton

1541104

registered interest
date	09/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when NHS England will publish its planned assessment of adherence to Excellence in Continence Care and its pandemic recovery and restoration plans.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	83559
answer	answer is ministerial correction date of answer 07/12/2022 answer text <p>NHS England will consider next steps on Excellence in Continence Care through its National Bladder and Bowel Health Project. Integrated care boards lead on plans for pandemic recovery and restoration plans, including for continence services.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 07/12/2022 12:53:44 answering member 4527 label Biography information for Helen Whately previous answer version 34627 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679
tabling member	1538 label Biography information for Rosie Cooper

1541105

registered interest
date	09/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve continence services through the National Bladder and Bowel Health Project.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	83560
answer	answer is ministerial correction date of answer 17/11/2022 answer text <p>The Project’s objectives are to improve continence care and to further research and implement recommendations from ‘Excellence in Continence Care’, published in 2018. The Project will meet in December to evaluate progress on bladder and bowel pathways and to consider next steps.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 17/11/2022 11:18:46 answering member 4527 label Biography information for Helen Whately
tabling member	1538 label Biography information for Rosie Cooper

1505868

registered interest
date	07/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to respond to the letter of 24 June 2022 from the hon. member for West Lancashire on staffing levels in clinical radiology and clinical oncology, reference ZA60022.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	49103
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>We replied to the hon. Member on 19 August 2022.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:01:42 answering member 4320 label Biography information for Robert Jenrick
tabling member	1538 label Biography information for Rosie Cooper

1489283

registered interest
date	14/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the correspondence of 25 May 2022 from the Hon. Member for West Lancashire, reference ZA59821, regarding support for people with allergies.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	36726
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>We replied to the hon. Member on 18 July 2022.</p><p> </p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/07/2022 16:36:25 answering member 4492 label Biography information for Maria Caulfield
tabling member	1538 label Biography information for Rosie Cooper

1488075

registered interest
date	11/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter of 29 April 2022 from the hon. member for West Lancashire to his predecessor, regarding arthritis analgesia, reference ZA59617.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	33735
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>We replied to the hon. Member on 14 July 2022.</p><p> </p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/07/2022 15:27:25 answering member 4492 label Biography information for Maria Caulfield
tabling member	1538 label Biography information for Rosie Cooper